Update on laser treatment of diabetic macular edema

International Ophthalmology Clinics

Volumn 49, Issue 2, 2009, Pages 87-94

  Ahmadi, M Ahmir ^a   Lim, Jennifer I ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSAL ATTRIBUTION; DIABETIC MACULAR EDEMA; HUMAN; LASER COAGULATION; LASER SURGERY; LOW LEVEL LASER THERAPY; PRIORITY JOURNAL; REVIEW; VISUAL IMPAIRMENT; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; PATHOLOGY; RETINA MACULA EDEMA; RETINA MACULA LUTEA; TREATMENT OUTCOME;

FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; LASER COAGULATION; MACULA LUTEA; MACULAR EDEMA; TREATMENT OUTCOME;

EID: 67650215674     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31819fd6b2     Document Type: Review

References (34)

1. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No. 1. Arch Ophthalmol. 1985;103:1796-1806.
2. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 1995;102:7-16.
3. Bresnick GH. Diabetic Retinopathy. In: Peyman GA, Sanders DR, Goldberg MF, eds. Principles and Practice of Ophthalmology. Philadelphia: WB Saunders; 1980:1237-1241.
4. Kearns M, Hamilton AM, Kohner EM. Excessive permeability in diabetic maculopathy. Br J Ophthalmol. 1979;63:489-497.
5. Bresnick GH. Diabetic maculopathy; a critical review highlighting diffuse macular edema. Ophthalmology. 1983;90:1301-1317.
6. Royster AJ, Nanda SK, Hatchell DL, et al. Photochemical initiation of thrombosis. Fluorescein angiographic, histologic and ultrastructural alterations in the choroid, retinal pigment epithelium and retina. Arch Ophthalmol. 1988;106:1608-1614.
7. Wilson DJ, Finkelstein D, Quigley HA, et al. Macular grid photocoagulation. An experimental study on the primate retina. Arch Ophthalmol. 1988;106:100-105.
8. Ogata N, Tombran-Tink J, Jo N, et al. Upregulation of pigment epithelium-derived factor after laser photocoagulation. Am J Ophthalmol. 2001;132:427-429. (Pubitemid 32768625)
9. Early Treatment Diabetic Retinopathy Study Research Group. Report 9. Early photocoagulation for diabetic retinopathy. Ophthalmology. 1991;98(5 suppl):766-785.
10. Early Treatment Diabetic Retinopathy Study Research Group. Report 2. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Ophthalmology. 1987;94:761-774.
11. Glaser BM. Extracellular modulating factors and the control of intraocular neovascularization. An overview. Arch Ophthalmol. 1988;106:603-607.
12. Lerman S. An experimental and clinical evaluation of lens transparency and aging. J Gerontol. 1983;38:293-301.
13. Akduman L, Olk J. Diode Laser (810 nm) versus Argon Green (514 nm) modified grid photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1977;104:1433-1441.
14. Schatz H, Madeira D, McDonald HR, et al. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol. 1991;109:1549-1551.
15. Roider J. Laser treatment of retinal diseases by subthreshold laser effects. Semin Ophthalmol. 1999;14:19-26. (Pubitemid 29215307)
16. Morgan CM, Schatz H. Atrophic creep of the retinal pigment epithelium after focal macular photocoagulation. Ophthalmology. 1989;96:96-103. (Pubitemid 19041335)
17. Varley MP, Frank E, Purnell EW. Subretinal neovascularization after focal argon laser for diabetic macular edema. Ophthalmology. 1988;95:567-573. (Pubitemid 18117699)
18. Ulbig MW, McHugh DA, Hamilton AM. Diode laser photocoagulation for diabetic macular edema. Br J Ophthalmol. 1995;79:318-321.
19. Gunduz K, Arden GB. Changes in color contrast sensitivity associated with operating argon lasers. Br J Ophthalmol. 1989;73:241-246. (Pubitemid 19117545)
20. Laursen ML, Moeller F, Sander B, et al. Subthreshold micropulse diode laser treatment in diabetic macular edema. Br J Ophthalmol. 2004;88:1173-1179. (Pubitemid 39141379)
21. McHugh JDA, Marshall J, Ffytche TJ, et al. Initial clinical experience using a diode laser in the treatment of retinal vascular disease. Eye. 1989;3(Pt 5):516-527. (Pubitemid 20018422)
22. Bailey CC, Sparrow JM, Grey RH, et al. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes. Eye. 1999;13(Pt 2):151-159.
23. Geeraets WJ, Berry ER. Ocular spectral characteristics as related to hazards from lasers and other light sources. Am J Ophthalmol. 1968;66:15-20.
24. Friberg TR, Karatza EC. The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser. Ophthalmology. 1997;104:2030-2038.
25. Roider J, Brinkmann R, Wirbelauer C, et al. Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study. Br J Ophthalmol. 2000;84:40-47. (Pubitemid 30251632)
26. Moorman CM, Hamilton AM. Clinical applications of the MicroPulse diode laser. Eye. 1999;13(Pt 2):145-150. (Pubitemid 29210130)
27. Stanga PE, Reck AC, Hamilton AM. Micropulse laser in the treatment of diabetic macular edema. Semin Ophthalmol. 1999;14:210-213. (Pubitemid 30061163)
28. Do DV, Nguyen QD, Heier JS, et al, Campochiaro; The READ2 Investigators. Six- Month Results of the READ2 Study: Ranibizumab for Edema of the Macula in Diabetes - A Phase 2 Clinical Trial. American Society of Retinal Specialists Annual Meeting, 2008 (abstract).
29. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115:1447-1449.
30. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
31. UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes (UKPDS 33). Lancet. 1998;352:837-853. (Pubitemid 28416718)
32. UK Prospective Diabetes Study Group. Tight blood pressure control and the risk of macrovascular and microvascular complications in type II diabetes: UKPDS 38. BMJ. 1998;317:703-713. (Pubitemid 28414300)
33. Klein BE, Moss SE, Klein R, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 1991;98:1261-1265.
34. Chew EY, Klein ML, Ferris FL III, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114:1079-1084.